This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PQ912/PBD-C06 (Combination)

Probiodrug AG

Drug Names(s): PQ912, PBD-C06

Description: PQ912/PBD-C06 is a combination therapy of glutaminyl cyclase-inhibtor PQ912 and pGlu-Abeta specific antibody PBD-C06.

PQ912/PBD-C06 (Combination) News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug